Latest Market Prices News

BMC Minerals Ltd. reported a strong cash position of $64.9 million following its December 2025 ASX listing, supported by significant financing inflows and a secured agreement with Wheaton Precious Metals Corp.

Future Metals NL has outlined strategic initiatives to enhance its flagship Panton PGM Project, leveraging rising platinum group metal prices and new processing opportunities. Key work programs and management appointments position the company for accelerated development in 2026.

Stockland announces a 9-cent unfranked dividend for the half-year ending December 2025, alongside a Dividend Reinvestment Plan priced at $5.47 per security. The DRP offers investors a 1% discount and new securities issued will rank equally from the issue date.

Metals Australia Ltd is progressing pre-feasibility studies for its Lac Carheil Graphite Project in Quebec, aligning with the province’s new strategy to accelerate critical minerals development. The project’s expanded resource and downstream battery material plans position it well for North American markets.

GWR Group Limited reports a robust cash position of $75 million and progresses its Prospect Ridge Magnesite Project alongside strategic investments in tungsten and royalties from iron ore and gold assets.

Lithium Universe’s Bécancour Lithium Refinery project in Québec is poised to capitalise on a sharp lithium price rebound, with current prices well above feasibility study forecasts. The company’s counter-cyclical development strategy is gaining momentum amid renewed market confidence.

Highfield Resources has secured a A$10 million investment from existing strategic shareholders, extending its financial runway through early 2027 while awaiting a critical Spanish Supreme Court ruling on its Goyo mining permit appeal.

A takeover premium blew the doors off the Materials board this week, while one discounted equity raise did the opposite. Uranium names kept climbing on real production progress, and rare earths stayed in favour as governments and buyers circle supply.

Assetora Limited has announced a $4 million pro-rata rights issue priced at $0.16 per share, with half the offer underwritten by existing shareholders to strengthen its balance sheet and repay debt.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Elementos Limited has confirmed significant extensions of tungsten and rubidium mineralisation at its Cleveland Tin Project, with new assay results from historic drill core set to feed into an updated resource estimate due next month.

AMCIL Limited has announced a fully franked ordinary dividend of AUD 0.01 per share for the half-year ending December 2025, with options for dividend reinvestment and bonus securities.